Delivery Order SPE2DB20D1004-SPE2DB24FF8X0
Award Date
4/24/24
Potential Completion Date
4/25/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,265.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of LAMOTRIGINE ER 100 MG TABLET 30S, a generic medication, with a performance period extending through March 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp to provide Lamotrigine ER 50 mg tablets. The award is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to support military healthcare programs and facilities worldwide....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 200 mg Tablets in quantities of 30. The $3,349.80 contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of August 18, 2022 and was awarded on August 17, 2022. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award, identified as SPE2DB25D3504|SPE2DB25FVTSS, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $1,031.90, is for the delivery of lamotrigine ER 300 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,477.21 firm-fixed-price delivery order is for the supply of Lamotrigine ER 100 mg tablets to support federal healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November...
This federal contract award, valued at $3,128.25, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lamotrigine ER 250 mg tablets, a pharmaceutical product used to treat certain mental health conditions. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen...
This federal contract award, identified as SPE2DB20D1051|SPE2DB25FD7FY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ER 250 mg tablets, a generic medication used to treat seizures and bipolar disorder. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,371.75 and an ultimate completion date of March 7, 2025. The...
This federal contract award, valued at $1,280.53, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lamotrigine ER 300 mg tablets for a period ending on September 19, 2024. This is a firm fixed-price delivery order contract, which is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lamotrigine ER 25 mg tablets. The contract has a ceiling value of $4,212.78 and a period of performance through February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 50 mg tablets. The contract is a firm-fixed price arrangement with a ceiling value of $7,987.56 and a period of performance through August 13, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...